View the SYMBYAX Mechanism of Action Video
As a healthcare professional, you know that treatment for patients with bipolar depression is as unique as each patient. SYMBYAX is a viable option to consider; it has been shown to affect neurotransmitters important in treating bipolar depression: serotonin, dopamine and norepinephrine.
Choose a connection speed and format type to view the video.
 |
High Resolution | Low Resolution |
 |
High Resolution | Low Resolution |
 |
High Resolution | Low Resolution |
NOTE: To view or print PDF files, you must have Adobe® Reader®. Click here to download the free reader.
